OCULIS ANNOUNCES AN OVERSUBSCRIBED US$57 MILLION SERIES C FINANCING
New leading international life science investors join current institutional investors with proceeds to: Advance novel, late-stage Investigational ophthalmology drugs OCS-01
Category: Pharma applications
Why deliver a statin in form of inclusion complex with hydrophilic cyclodextrin?
In this work, the effects of simvastatin (SIM), 2-hydroxypropyl)-β-cyclodextrin (HPβCD) and their complex (SIM: HPβCD) on the structure and properties
The talks of webinar “Meet the Experts: Applications of Cyclodextrins in the Pharma Industries” on youtube
The webinar held on Apr. 15-16, 2021 and organized by Cyclolab received wide attantion. It was in the afternoon Central
CD as Drug: Hydroxypropyl Cyclodextrin Improves Amiodarone-induced Aberrant Lipid Homeostasis of Alveolar Cells
Alveolar epithelial type II (AT2) cells secrete pulmonary surfactant via lamellar bodies (LBs). Abnormalities in LBs are associated with pulmonary
Inhaled budesonide in the treatment of early COVID-19
The Lancet published on an open-label, parallel-group, phase 2, randomised controlled trial, on inhaled budesonide (Ramakrishnan et al. 2021). Participants
Cyclo Therapeutics Announces Design of Pivotal Phase 3 Study Evaluating Trappsol® Cyclo™ in Niemann-Pick Type C1
Cyclo Therapeutics, Inc., a clinical stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and
Targeting Lipid Rafts as a Strategy Against Coronavirus
Lipid rafts are functional membrane microdomains containing sphingolipids, including gangliosides, and cholesterol. These regions are characterized by highly ordered and
Cyclodextrins applied for improved insulin therapy
A recently published patent application (US20210113666 – Systems, Methods and Products for Minimizing Tissue Reactions and Tissue Injury at an
Cyclodextrin dimers: a versatile approach to optimizing encapsulation and their application to therapeutic extraction of toxic oxysterols
A novel class of specifically engineered, dimerized cyclodextrin nanostructures was developed for the encapsulation of toxic biomolecules such as 7-ketocholesterol
Results of the survey at the CycloLab’s webinar on pharmaceutical applications of cyclodextrins Day 2
During the webinar of CycloLab “Getting the best out of cyclodextrins” held on Apr.15-16, 2021, the participants could answer to